標(biāo)題: Titlebook: Nanomedicine for Cancer Therapy; From Chemotherapeuti Piyush Kumar,Rohit Srivastava Book 2017 The Author(s) 2017 Drug delivery for cancer.C [打印本頁(yè)] 作者: otitis-externa 時(shí)間: 2025-3-21 19:49
書目名稱Nanomedicine for Cancer Therapy影響因子(影響力)
書目名稱Nanomedicine for Cancer Therapy影響因子(影響力)學(xué)科排名
書目名稱Nanomedicine for Cancer Therapy網(wǎng)絡(luò)公開(kāi)度
書目名稱Nanomedicine for Cancer Therapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Nanomedicine for Cancer Therapy被引頻次
書目名稱Nanomedicine for Cancer Therapy被引頻次學(xué)科排名
書目名稱Nanomedicine for Cancer Therapy年度引用
書目名稱Nanomedicine for Cancer Therapy年度引用學(xué)科排名
書目名稱Nanomedicine for Cancer Therapy讀者反饋
書目名稱Nanomedicine for Cancer Therapy讀者反饋學(xué)科排名
作者: Irritate 時(shí)間: 2025-3-21 20:49
Nanomedicine for Cancer Therapy,. Cancer therapy itself is the vibrant topic, to make the topic simple and easy to understand, we have chosen breast cancer as our model system. In this book, the emphasis was on multiple drug resistance (MDR) and its mechanism, how to overcome it using nanoparticle approach.作者: COST 時(shí)間: 2025-3-22 01:33 作者: 拾落穗 時(shí)間: 2025-3-22 07:25
Book 2017rts on future generation based nanotherapeutics and cancer theranostic agent for effective therapeutic diagnosis and treatment. Breast cancer was chosen as the model system in this review. The authors give emphasis to multiple drug resistance (MDR) and its mechanism and how to overcome it using the 作者: 外觀 時(shí)間: 2025-3-22 10:10
Piyush Kumar,Rohit SrivastavaReports on clinical trials success and challenges.Details the mechanism of drug resistance.Includes supplementary material: 作者: Tractable 時(shí)間: 2025-3-22 14:38 作者: 神圣在玷污 時(shí)間: 2025-3-22 17:08 作者: 儲(chǔ)備 時(shí)間: 2025-3-22 22:56 作者: Infiltrate 時(shí)間: 2025-3-23 04:47
Nanomedicine for Cancer Therapy978-3-319-45826-7Series ISSN 2191-530X Series E-ISSN 2191-5318 作者: GRILL 時(shí)間: 2025-3-23 09:06 作者: humectant 時(shí)間: 2025-3-23 09:53 作者: objection 時(shí)間: 2025-3-23 17:02
y customizable high-quality products. Employees are one of the “most-valuable resources” to the management. However, the initial situation reveals significant improvement opportunities related to the employee involvement and empowerment concerning workplace re-design. The proposed subject-oriented s作者: heterodox 時(shí)間: 2025-3-23 19:34
Piyush Kumar,Rohit Srivastavaess Analyses are a first step of Business Process Management to identify weak spots and potential improvements within processes. Even a rough documentation of processes in a graphical way, a so-called process model, raises process awareness and transparency for all involved parties. However, it is n作者: 大量殺死 時(shí)間: 2025-3-23 22:21 作者: 蘆筍 時(shí)間: 2025-3-24 03:13
5樓作者: Harrowing 時(shí)間: 2025-3-24 07:01
5樓作者: CHASM 時(shí)間: 2025-3-24 11:12
6樓作者: 漂浮 時(shí)間: 2025-3-24 17:53
6樓作者: FOLD 時(shí)間: 2025-3-24 22:58
6樓作者: CHURL 時(shí)間: 2025-3-25 01:40
6樓作者: 天文臺(tái) 時(shí)間: 2025-3-25 03:56
7樓作者: 深陷 時(shí)間: 2025-3-25 09:32
7樓作者: resuscitation 時(shí)間: 2025-3-25 12:49
7樓作者: MEET 時(shí)間: 2025-3-25 17:38
7樓作者: 記憶 時(shí)間: 2025-3-25 22:35
8樓作者: gregarious 時(shí)間: 2025-3-26 01:26
8樓作者: 安裝 時(shí)間: 2025-3-26 06:43
8樓作者: deforestation 時(shí)間: 2025-3-26 11:30
8樓作者: 不遵守 時(shí)間: 2025-3-26 14:39
9樓作者: 統(tǒng)治人類 時(shí)間: 2025-3-26 18:17
9樓作者: 擁護(hù)者 時(shí)間: 2025-3-26 21:40
9樓作者: Handedness 時(shí)間: 2025-3-27 04:52
9樓作者: SCORE 時(shí)間: 2025-3-27 08:22
10樓作者: 注意力集中 時(shí)間: 2025-3-27 13:06
10樓作者: Yourself 時(shí)間: 2025-3-27 14:22
10樓作者: 最后一個(gè) 時(shí)間: 2025-3-27 21:27
10樓
